Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05731713 · ClinicalTrials.gov registry record · NA
Journey of Transformation Curriculum for Native American Youth
A NA study of Substance Use and Alcohol Drinking, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 255
- Enrollment target
- 1
- Study location
NCT05731713: Recruiting NA study of Substance Use and Alcohol Drinking, sponsored by University of Washington.
NCT05731713 is a NA study of Substance Use and Alcohol Drinking that is actively recruiting participants, run by University of Washington. The registered enrollment target is 255 participants, below the 1,258-participant average among 88 other Substance Use trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05731713, a NA study of Substance Use and Alcohol Drinking, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 255 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators will conduct a waitlist control trial to test the efficacy of the Journey of Transformation-Native Youth Health Leadership Program (JOT) in terms of delaying or reducing tobacco and other substance use and improving sexual health.
Primary Outcome
Patterns of substance use (Monitoring the Future \[MTF\] 30-day self-report assessed on an ordinal scale \[0 occasions, 1-2 occasions, 3-5 occasions, 6-9 occasions, 10-19 occasions, 20-39 occasions, 40 or more occasions\]). Substances include tobacco, alcohol, marijuana, stimulants, inhalants, opioids, and other drugs.
Conditions Studied
Interventions
- BEHAVIORAL Journey of Transformation-Native Youth Health Leadership Program curriculum
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2023-12-11 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
What NCT05731713 shows while recruiting
NCT05731713 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, below the 1,258-participant average among 88 other Substance Use trials with a reported enrollment target (80% lower).
The record links to 4 conditions, with Substance Use appearing as the primary indexed condition, and to 1 intervention - of which Journey of Transformation-Native Youth Health Leadership Program curriculum is the first listed.
NCT05731713 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05731713 about?
NCT05731713 is a clinical study titled "Journey of Transformation Curriculum for Native American Youth". The investigators will conduct a waitlist control trial to test the efficacy of the Journey of Transformation-Native Youth Health Leadership Program (JOT) in terms of delaying or reducing tobacco and other substance use and improving sexual health.
What is the current status of trial NCT05731713?
This trial is currently recruiting. It is a NA study. The enrollment target is 255 participants. The study started on 2023-12-11. Estimated completion is 2027-02-28.
What conditions does trial NCT05731713 study?
This clinical trial studies the following conditions: Substance Use, Alcohol Drinking, Tobacco Use, Sexual Behavior.
What interventions are being tested in trial NCT05731713?
The interventions under investigation include: Journey of Transformation-Native Youth Health Leadership Program curriculum (BEHAVIORAL).
Who is sponsoring clinical trial NCT05731713?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05731713 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05731713's enrollment target sits among peer trials
255 39th of 88 higher than 50 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI